News
EU-AIMS webinars
The EU-AIMS Network will schedule several webinars in 2017. Talks will take place at 4.30pm CEST / 3.30pm BST. The webinars last approximately an hour and consist of a talk (30 minutes) followed by a Q&A discussion (20-30...[more]
EU-AIMS – one of the largest autism database
EU-AIMS builds up one of the richest autism database of its kind in the world. This database contains medical data of 450 people with autism spectrum disorders (ASD) and 300 babies with a high risk of developing autism. The data...[more]
EU-AIMS - the largest largest multi-centre, multi-disciplinary observational study on autism spectrum disorder in the world
Two companion papers on the EU-AIMS Longitudinal European Autism Project (LEAP) The LEAP group has recently published two companion papers in Molecular Autism. LEAP is currently the largest multi-centre, multi-disciplinary...[more]
EU-AIMS in the EU-commission brochure
EU-AIMS: A closer look at the many faces of autism. The EU-AIMS project is identifying the biological causes of autism and has developed innovative approaches to speed up development of new, more effective treatments for...[more]
Research Program Marks Milestone for Testing Future Clinical Trials in Autism Spectrum Disorder
EU-AIMS marks milestone for testing future clinical trials in Autism Spectrum Disorder. Read the success story: Roche [more]
Identification and validation of biomarkers for autism spectrum disorders
The next paper in Nature is online: nature The EU-AIMS Longitudinal European Autism Project (LEAP) is the largest clinical observational study in the world that combines genetics, neuroimaging, cognitive testing and clinical...[more]
Autism-Europe's international congress 16-18 September 2016, Edinburgh
Autism-Europe’s international congress is open. Please note that very early bird registration is possible until 31 October, so I would strongly encourage you to register asap [more]